Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 25, 2016

Gore announces first implant of Gore Synecor Biomaterial in hernia repair

W L Gore & Associates (Gore) has announced the first implant of the Gore Synecor Biomaterial in a robotically-assisted hernia repair at Our Lady of the Lake Hospital, Baton Rouge, Louisiana, US.

Gore

W L Gore & Associates (Gore) has announced the first implant of the Gore Synecor Biomaterial in a robotically-assisted hernia repair at Our Lady of the Lake Hospital, Baton Rouge, Louisiana, US.

Approved by the US Food and Drug Administration (FDA) last year, the new medical device is based on polytetrafluoroethylene (PTFE) and polyglycolic acid / trimethylene carbonate (PGA/TMC) bioabsorbable material.

The hybrid device is composed of Gore Bio-A Web tissue-building scaffold for rapid vascularity and in-growth, a macroporous knit of dense, monofilament PTFE fibers to provide strength and a nonporous PGA/TMC film that reduces tissue attachment to the device on the visceral side.

It offers an alternative for hernia repair surgeons who earlier had to choose between a permanent material for a durable, single-stage repair, or absorbable, non-permanent materials.

FACS Dr Karl LeBlanc said: "The combination of a permanent material with the absorbable portion is intended to increase ingrowth, strengthen the repair, and allow for lower recurrence rates in the process.

"The combination of a permanent material with the absorbable portion is intended to increase ingrowth, strengthen the repair, and allow for lower recurrence rates in the process."

"And, the product handles quite nicely, it has just the right amount of stiffness to make its use with the laparoscope or robot very easy."

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

The device is being evaluated in Gore’s clinical quality improvement (CQI), which is an alternate clinical study to allow a broader patient sample and adapt to clinical findings in real time.

Gore general medical products global leader Michael Koenke said: "Our ultimate objective with the CQI programme is to evaluate how to make hernia repair using Gore Synecor Biomaterial as successful as possible in regards to both the physician experience and patient outcomes."

The surgeons will not require a pre-certification to implant Gore Synecor biomaterial. However, Gore offers operating room support and peer-to-peer educational courses for interested surgeons.


Image: Gore Synecor Biomaterial. Photo: courtesy of Business Wire.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU